NINDS Funding Strategy Fiscal Year 2022

NINDS Funding Strategy Fiscal Year 2022

Mission

The mission of NINDS is to seek fundamental knowledge about the brain and nervous system and to use that knowledge to reduce the burden of neurological disease.

Operations Under a Continuing Resolution

The Department of Health and Human Services (HHS), including NIH, is operating under the “Extending Government Funding and Delivering Emergency Assistance Act” (Public Law 117-43) signed by President Biden on September 30, 2021. This Act (CR) continues government operations through December 3, 2021 at FY 2021 enacted level.

Consistent with NIH procedures identified under NOT-OD-22-045 and during the CRs of FY 2006 – 2021, the NIH will issue non-competing research grant awards at a level below that indicated on the most recent Notice of Award (generally up to 90% of the previously committed level). After FY 2022 appropriations are enacted, NIH hopes to adjust the awarded levels to 100% of the previously committed level, as it has done in previous years. However, as this upward adjustment is dependent on the 2022 budget level, NIH expects institutions to monitor their expenditures carefully during this period.

The table below describes the paylines for different categories of competing grant awards during the period of the CR. Applications within these paylines will be funded with rare, NANDS Council-approved exceptions. These paylines may be adjusted when the FY 2022 appropriation is enacted:

Investigators 

General Pay Line

All Investigators

14%

Early Stage Investigators

25%

For additional information, please view the NINDS Funding Strategy for fiscal year 2021 (FY21). The policies outlined in this strategy are for this fiscal year, unless otherwise stated.